Leishmania-HIV co-infection: An emerging problem in India [7]

AIDS

Volumn 20, Issue 8, 2006, Pages 1213-1215

  Redhu, Naresh S ^a   Dey, Ayan ^a   Balooni, Veena ^a   Singh, Sarman ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; LEISHMANIASIS; LETTER; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; ANTIBODIES, PROTOZOAN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INDIA; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED;

EID: 33646894714     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000226971.42622.4e     Document Type: Letter

References (17)

1. Guerin PJ, Olliaro P, Sundar S, Boelaert M, Croft SL, Desjeux P, et al. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2002; 2:494-501.
2. Singh S. Mucosal Leishmaniasis in an Indian AIDS patient. Lancet Infect Dis 2004; 4:660-661.
3. Pratlong F, Dedet JP, Marty P, Portus M, Deniau M, Dereure J, et al. Leishmania-human immunodeficiency virus coinfection in the Mediterranean basin: isoenzymatic characterization of 100 isolates of the Leishmania infantum complex. J Infect Dis 1995; 172:323-326.
4. Desjeux P, Meert JP, Piot B, Alwar J, Medrano FJ, Portus M, et al. Leishmania/HIV co-infection, South Western Europe 1990-98. Document WHO/LEISH/2000. 42, Geneva: World Health Organization.
5. Rabello A, Orsini M, Disch J. Leishmania/HIV coinfection in Brazil: an appraisal. Ann Trop Med Parasitol 2002; 97:17-28.
6. Paredes R, Munoz J, Diaz I, Domingo P, Gurgui M, Clotet B. Leishmaniasis in HIV infection. J Post Grad Med 2003; 49:39-49.
7. Singh S, Biswas A, Wig N, Aggarwal P, Sood R, Wali JP. A new focus of visceral leishmaniasis in sub-Himalayan (Kumaon) region of northern India. J Commun Dis 1999; 31:73-77.
8. Singh S, Kumar J, Singh R, Dwivedi SN. Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community- based study. Int J Infect Dis 2000; 4:203-208.
9. Singh S, Dwivedi SN, Sood R, Wali JP, Hepatitis B. C and human immunodeficiency virus infections in multiply injected kala-azar patients in Delhi. Scand J infect Dis 2000; 32:3-6.
10. Sinha PK, Rabidas VN, Pandey K, Verma N, Gupta AK, Ranjan A, et al. Visceral Leishmaniasis and HIV Co-infection in Bihar, India [Letter]. J Acquir Immune Defic Syndr 2003; 32:115-116.
11. Pandey K, Sinha PK, Ravidas VN, Kumar N, Verma N, Lal CS, et al. Nexus of infection with Human Immunodeficiency Virus, pulmonary tuberculosis and visceral Leishmaniasis: A case report from Bihar, India. Am J Trop Med Hyg 2005; 72:30-32.
12. Singh S, Kumari V, Singh N. Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen. Clin Diagn Lab Immunol 2002; 9:568-572.
13. Sivakumar R, Sharma P, Chang KP, Singh S. Cloning, expression, and purification of a novel recombinant antigen from Leishmania donovani. Protein Expr Purif 2006; 46:156-165.
14. Singh S, Sivakumar R. Recent advances in the diagnosis of leishmaniasis. J Postgrad Med 2003; 49:55-60.
15. Medrano FJ, Canãvate C, Leal M, Rey C, Lissen E, Alvar J. The role of serology in the diagnosis and prognosis of visceral Leishmaniasis in patients co-infected with HIV-1. Am J Trop Med Hyg 1998; 59:155-162.
16. Mosier D, Sieburg H. Macrophage-tropic HIV: critical for AIDS pathogenesis? Immunol Today 1994; 15:332-339.
17. Aranka A. Treating HIV/AIDS and Leishmaniasis co infection in Ethiopia. JAMC 2005; 11:172.